An evaluation of emerging vaccines for childhood pneumococcal pneumonia

Background Pneumonia is the leading cause of child mortality worldwide. Streptococcus pneumoniae (SP) or pneumococcus is estimated to cause 821,000 child deaths each year. It has over 90 serotypes, of which 7 to 13 serotypes are included in current formulations of pneumococcal conjugate vaccines tha...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	BMC public health Ročník 11; číslo Suppl 3; s. S26
Hlavní autori:	Webster, Julia, Theodoratou, Evropi, Nair, Harish, Seong, Ang Choon, Zgaga, Lina, Huda, Tanvir, Johnson, Hope L, Madhi, Shabir, Rubens, Craig, Zhang, Jian Shayne F, El Arifeen, Shams, Krause, Ryoko, Jacobs, Troy A, Brooks, Abdullah W, Campbell, Harry, Rudan, Igor
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	London BioMed Central 13.04.2011 Springer Nature B.V BMC
Predmet:	Biostatistics Child Cost-Benefit Analysis Developing countries Developmental stages Disease Environmental Health Epidemiology Global Health Health sciences Humans Industrialized nations International policy LDCs Medicine Medicine & Public Health Mortality Nutrition research Pharmaceutical industry Pneumococcal Vaccines - economics Pneumonia Pneumonia, Pneumococcal - mortality Pneumonia, Pneumococcal - prevention & control Proteins Public Health Regulatory approval Streptococcus infections Streptococcus pneumoniae - immunology Systematic review Vaccine Vaccines Vaccines, Conjugate - economics Bangladesh United States > US Asia Africa Croatia Pneumococcal Disease Invasive Pneumococcal Disease Vaccine Serotypes Pneumococcal Conjugate Vaccine Pneumococcal Pneumonia
ISSN:	1471-2458, 1471-2458
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!